RAND Health Advisory Board
List updated March 2021
John J. Rydzewski
Senior Advisor, PJ Solomon, U.S. Investment Banking Arm of Natixis
Mr. Rydzewski serves as a Senior Advisor to PJ Solomon, the U.S. Investment Banking arm of Natixis. Prior to PJ Solomon he co-founded a pre-clinical stage biotech company developing cancer-targeting immuno-therapeutics with technology licensed from the Massachusetts Institute of Technology and Harvard University. He was a Managing Director focused on structured credit investments in the pharmaceutical sector at Christofferson, Robb & Co. Earlier, as an investment banker, he provided advisory and capital raising services for companies in multiple health care industry sectors including biotechnology and drug development services; medical devices; hospital management and long-term care, including assisted living and skilled nursing care; behavioral health; and managed care. He was the senior manager in the Bankruptcy and Insolvency Group of Price Waterhouse & Co. He has served as a director of numerous health care companies. He currently serves as a director of Turn-Key Health and he is a member of the Board of Overseers of the University of Pennsylvania’s School of Nursing. He received both an MBA and BS from The Wharton School of the University of Pennsylvania and obtained a CPA license.
Karen L. Katen
Senior Advisor, Essex Woodlands Health Ventures
Former Vice Chairman, Pfizer and President, Pfizer Human Health/Pfizer Pharmaceuticals Group; former Director of Harris Corporation, The Home Depot, Air Liquide, and Takeda Global Advisory Board
Karen Katen is a senior advisor to Essex Woodlands, a health care investment company. She serves on the boards of the Harris Corporation, The Home Depot, Air Liquide, and IMS Health. In addition, she serves on the Economic Club of New York Board of Trustees, the Takeda Global Advisory Board, and as chairman of ARMGO Pharmaceuticals. Karen joined Pfizer in 1974 after receiving her BA and MBA from the University of Chicago, where she now serves as a University Trustee and council member of its Booth School of Business. Karen retired in 2007 as vice chairman of Pfizer Inc., and as president of Pfizer Human Health/Pfizer Pharmaceuticals Group. She has served as chairman of the Pfizer Foundation, the company’s philanthropic arm devoted to supporting health care access, education, and community outreach initiatives around the world.
She has served on several health care–related boards, including as treasurer for PhRMA and the National Alliance for Hispanic Health, and was also a member of the Healthcare Leadership Council. Karen also has been active on a variety of international policy bodies, including as chairman, U.S.– Japan Business Council, and as a board member for the Peterson Institute for International Economics.
Joseph P. Sullivan
Senior Strategic Advisor, Riordan, Lewis, & Haden
Immediate Past Chairman, UCLA Medical Center Board of Advisors; former CEO American Health Properties, Inc. and later director of HCP, Inc; former Director, CIGNA Corporation
Mr. Sullivan is a private investor and immediate past chairman of the Board of Advisors of the UCLA Medical Center. He serves on the board of HCP, Inc., one of the largest health care real estate investment trusts (REIT). He served for six years as a director of CIGNA Corporation, a global health care company. In addition, he is a senior strategic advisor to Riordan, Lewis & Haden, a leading private equity firm. He was a director of Amylin Pharmaceuticals (2003–2012) through its sale to Bristol Meyers-Squibb and a director of MPG Office Trust through its sale to Brookfield Properties in 2013.
Mr. Sullivan served as Chairman and CEO of Protocare, Inc., a clinical trials and pharmaceutical industry consulting firm, for three years. He joined Protocare after seven years as Chairman and CEO of American Health Properties, Inc., a New York Stock Exchange REIT. Previously he had been an investment banker with Goldman, Sachs & Co. for 20 years. He holds an MBA from the Harvard Graduate School of Business Administration and a law degree and a BS from the University of Minnesota.
Andrea G. Barthwell, MD, DFASAM
Chief Executive Officer and Founder, Two Dreams
Former Chief Medical Officer, Treatment Management Company; Founder and CEO, EMGlobal LLC; former Deputy Director for Demand Reduction, Office of National Drug Control Policy; former President, American Society of Addiction Medicine
Andrea Grubb Barthwell, MD, DFASAM, is the Chief Medical Officer for Treatment Management Company and the founder and CEO of Two Dreams. She is also the founder and Chief Executive Officer of the Washington, DC-based global health care and policy-consulting firm EMGlobal LLC.
Dr. Barthwell served as Deputy Director for Demand Reduction in the Office of National Drug Control Policy (ONDCP) under President George W. Bush from 2002 to 2004. As a member of the President's sub-cabinet, Dr. Barthwell was a principal advisor on policies aimed at reducing the demand for illicit drugs.
Dr. Barthwell received a Bachelor of Arts degree in Psychology from Wesleyan University and a Doctorate of Medicine from the University of Michigan Medical School. She was a founding member of the Chicago Area AIDS Task Force, and was President of the American Society of Addiction Medicine (ASAM).
In 2003, Dr. Barthwell received the Betty Ford Award from the Association for Medical Education and Research in Substance Abuse. In 1997, Dr. Barthwell's peers named her one of the "Best Doctors in America" in addiction medicine.
Otis W. Brawley, MD, MACP, FASCO, FACE
Bloomberg Distinguished Professor of Oncology and Epidemiology, John Hopkins University
Former Chief Medical and Scientific Officer, American Cancer Society
Dr. Brawley is the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University. He leads a broad interdisciplinary research effort focused on cancer health disparities at the Johns Hopkins School of Medicine, the Bloomberg School of Public Health and the Sidney Kimmel Comprehensive Cancer Center. He is a member of the National Cancer Institute Board of Scientific Advisors and the National Academy of Medicine.
His work focuses on how to close racial, economic, and social inequalities in the prevention, detection, and treatment of cancer, and is concentrated on the appropriate practice of evidence-based medicine.
Dr. Brawley was chief medical and scientific officer of the American Cancer Society from 2007 to 2019. He earlier served as director of the Georgia Cancer Center at Grady Memorial Hospital in Atlanta, and as professor of hematology, oncology, medicine, and epidemiology at Emory University.
Dr. Brawley is a graduate of University of Chicago, Pritzker School of Medicine. He completed an internal medicine residency at Case-Western Reserve University and a fellowship in medical oncology at the National Cancer Institute.
Michael J. Critelli
Chief Executive Officer, MoveFlux Corporation
Former CEO, Dossia Service Corporation; former Chairman and CEO, Pitney Bowes
Michael J. Critelli is the President and CEO of MoveFlux Corporation, an organization designed to deploy artificial intelligence for a variety of use cases, including healthcare services. He previously was the CEO of Dossia Service Corporation, a firm which deployed a lifelong, secure, portable, patient-controlled health record, and a Board member of ProHealth Physicians.
He serves on the Boards of Eaton Corporation, ConferMED, PowerMyLearning, the Regional Plan Association, and Imagine Solutions and the advisory boards of Wellville and the Harvard School of Public Health, where he has an adjunct faculty appointment.
He retired from Pitney Bowes in 2009, after a distinguished 30-year career, in which he served for 11 years as chief executive officer and 12 as chairman and built a globally acclaimed employer-based health care program.
He also has produced a theatrically released full-length feature film entitled From the Rough, based on the true story of the first black woman to coach a men’s college athletic team.
He is a graduate of the University of Wisconsin and Harvard Law School.
Susan G. Dentzer
Senior Policy Fellow, Duke Margolis Center for Health Policy
Former President and CEO, Network for Excellence in Health Innovation; former Editor-in-Chief, Health Affairs
Susan Dentzer is one of the nation's most respected health and health policy thought leaders and a frequent speaker and commentator on television and radio and an author of commentaries in Modern Healthcare, the New England Journal of Medicine, and other prominent publications. She is currently a Senior Policy Fellow at the Duke-Margolis Center for Health Policy. She is the editor and lead author of the book, Health Care Without Walls: A Roadmap for Reinventing U.S. Health Care.
Dentzer previously served as President and Chief Executive Officer of the Network for Excellence in Health Innovation; was senior policy adviser to the Robert Wood Johnson Foundation; editor-in-chief of the journal Health Affairs; and on-air Health Correspondent for the PBS NewsHour. She is an elected member of the National Academy of Medicine and is a fellow of the National Academy of Social Insurance and the Hastings Center.
Dentzer graduated from Dartmouth and chaired the Dartmouth Board of Trustees from 2001 to 2004. Dentzer holds an honorary Master's Degree from Dartmouth and an honorary doctorate in humane letters from Muskingum University.
Co-Founder and CEO, Rebel Health/ARCHANGELS; Prudential's Wellness Expert
Cashier-on-leave, Walmart; Co-Founder, Eliza Corporation
Alexandra Drane is co-founder and CEO of Rebel Health/ARCHANGELS. She serves as Wellness Expert for Prudential, and co-founded Eliza Corporation (acquired by HMS Holdings Corp: HMSY), Engage with Grace, and three other companies (all boot-strapped). A serial entrepreneur, she is also a cashier-on-leave for Walmart. She believes retail is the front line of health, that caregivers are our country’s greatest asset, and that we need to expand the definition of health to include life.
Alexandra sits on the Leadership Council for the Rosalynn Carter Institute, the Entrepreneurs Council for The United States of Care, the Board of Advisors for Open Notes, and Harvard Medical School’s Executive Council of the Division of Sleep Medicine. She is a Governor-appointed member of the Executive Committee for the Board of Directors for MassTech, a member of the Board of Directors of C-TAC, and has served as the Vice Chair of the Board of Trustees of BIDMC (a Harvard Teaching Hospital). Alex was named 2019 Top Women in Health Care’s Entrepreneur of the Year by PR News, one of Disruptive Women in Health Care’s Women to Watch in 2014, one of Boston Globe’s 2013 Top 100 Women Leaders, and Boston Business Journal’s “40 Under 40”, as well as an inventor on multiple patents. She joined Prudential Financial in a film series called “The State of US” that generated close to two billion impressions. She has one hobby outside of her passion for revolutionizing health care, and her love of family and adventure...car racing.
Jean Drouin, MD, MBA, AB
Founder and CEO, Clarify Health
Former Senior Partner and Founder of McKinsey and Company’s Advanced Healthcare Analytics Practice
Jean Drouin is a leader with over 25 years of experience in health care management, technology, operations, finance, and cultural change. As CEO, Jean focuses on creating the environment that allows Clarify to deliver on its mission by delighting customers and growing a great team. Jean leads the Executive Leadership Team which sets the company's vision and strategy and is responsible for ensuring the company's overall success. Jean believes that health care has been held back by a lack of actionable insights, and that by integrating innovative analytics and incentives, we can power better health and outcomes. Prior to founding Clarify, Jean was a Senior Partner at McKinsey, where he led the Healthcare Digital and IT practice. He also built and served as the founding Head of McKinsey Advanced Healthcare Analytics (MAHA), which provided services and products on health care reform, consumer analytics, new payment and pricing models, and risk management. Jean spent several years in the UK, where he helped set up the hospital regulator and served as the Head of Strategy for NHS London, a $15 billion organization which oversaw London’s hospitals, primary and social care. Jean holds an MD and MBA from Stanford University and an AB in Molecular Biology from Princeton. He is a Trustee of the Mailman School of Public Health at Columbia University, and the former Vice-Chair of the Board of Lester B. Pearson United World College of the Pacific.
Executive Vice President and Chief Strategy Officer, Henry Ford Health System
Carladenise Armbrister Edwards, PhD, serves as EVP/Chief Strategy Officer at Henry Ford Health System. She provides executive counsel and leadership for the system’s strategic transformational initiatives, partnership ventures, business development, government affairs, as well as Henry Ford Innovations, a multi-disciplinary team responsible for product design and commercialization, technology transfer, licensing agreements and international programs.
Dr. Edwards has nearly three decades of health care, nonprofit and government experience. Additional executive leadership roles include chief strategy officer for Providence St. Joseph Health (2016-2020) and Alameda Health System (2013-2016). She served as founding president and CEO of a nonprofit corporation, which governed California's electronic Health Information Exchange, held leadership roles in Georgia’s Department of Community Health, and advised healthcare, technology and nonprofit clients as principal advisor and CEO with a Florida based consulting firm.
She has a PhD in Medical Sociology from the University of Florida, a Master's degree in Education and Psychological Services and Bachelor's degree in Sociology from the University of Pennsylvania. She resides in Michigan with her husband (Herman), two children (William and Zora) and their goldendoodle (Vinny).
Elliot J. Favus, MD
Founder and CEO, Favus Institutional Research
Former investment management roles at Lazard Capital Markets and Och-Ziff Capital Management Group
Elliot Favus is Founder and CEO of Favus Institutional Research, a health care equity research consulting firm serving institutional investors. The firm uses fundamental analysis to evaluate the health care sector, with a focus on commercial, clinical data, legal, reimbursement, and regulatory catalysts. Elliot has been working as a health care equity research analyst on Wall Street since 2006. Prior to founding Favus Institutional Research in 2009, Elliot gained equity research and institutional investment management experience at Lazard Capital Markets and Och-Ziff Capital Management Group. Prior to working on Wall Street, Dr. Favus was an Instructor in Medicine at Mount Sinai School of Medicine in New York. He is a graduate of The University of Michigan (B.A.), The University of Chicago Pritzker School of Medicine (M.D.), and the NYU-Bellevue Hospital Internal Medicine Residency Program. He became board-certified in Internal Medicine in 2004. Dr. Favus has 10 years of basic science laboratory experience, working on human genetics projects at Harvard Medical School, The University of Chicago, and the University of Pittsburgh. He serves on the Board of Directors of two development-stage biotechnology companies: FirstString Research and Anavex Life Sciences.
David T. Feinberg, MD, MBA
Vice President, Google Health
Former President and CEO, Geisinger; former CEO, UCLA Health
Dr. David Feinberg currently heads up Google's health efforts. Previously, David was president and CEO of Geisinger, one of the nation's most innovative health services organizations. While at Geisinger, David oversaw 13 hospital campuses, a 600,000-member health plan, research centers, and various initiatives aimed at better engaging patients around their health and wellbeing. Prior to Geisinger, David served as CEO of UCLA's hospitals and associate vice chancellor of UCLA Health Sciences, as well as president of UCLA Health System.
Dr. Feinberg earned his undergraduate degree at the University of California, Berkeley. He graduated with distinction from the University of Health Sciences/Chicago Medical School. He completed an internship in pediatrics at Loyola University Medical Center, and residency and fellowship training in psychiatry, addiction psychiatry, and child and adolescent psychiatry at the UCLA School of Medicine. He earned a Master of Business Administration from Pepperdine University. A well-known national speaker and author of numerous articles and co-author of "ProvenCare," Dr. Feinberg is a member of the Alpha Omega Alpha Medical Honor Society, a Distinguished Fellow of the American Psychiatric Association and received the Cancro Academic Leadership Award from the American Academy of Child & Adolescent Psychiatry.
Jonathan E. Fielding, MD, MPH, MBA
Distinguished Professor, UCLA Fielding School of Public Health and UCLA Geffen School of Medicine
Former Director, Los Angeles County Department of Public Health; former Commissioner, Los Angeles First 5 Commission; former Massachusetts Commissioner of Public Health
Dr. Jonathan E. Fielding, MD, MPH, MBA is a Distinguished Professor at UCLA in the schools of Public Health and Medicine where he is conducting research in health impact assessment and health forecasting within the Center for Health Advancement which he founded.
Dr. Fielding recently completed 16 years of service as the Director of Los Angeles County Department of Public Health and the County Health Officer. Formerly he served as Commissioner of the Los Angeles First 5 Commission and as the Commissioner of Public Health for Massachusetts.
He chairs the U.S. Community Preventive Services Task Force, was a founding member of the U.S. Clinical Preventive Services Task Force, and cofounded the Big Cities Health Coalition. He is Editor of the Annual Review of Public Health and chairs the Board of the American Legacy Foundation. He is a Presidential appointee to the national Advisory Group on Prevention, Health Promotion, and Integrative and Public Health and an elected member of the Institute of Medicine.
Dr. Fielding received medical, public health, and history of science degrees from Harvard University and an MBA from the Wharton School of Business.
Patrick J. Frawley
Director, Catholic Charities of Brooklyn and Queens
Founder and Co-Founder and former CEO, Fidelis Care; former Senior Vice President for Social Responsibility, Centene
Pat Frawley recently concluded his service with Centene Corporation (NYSE: CNC), a managed care organization serving government-sponsored programs such as Medicaid, Medicare, and the Health Exchange. He previously held the position of CEO of Fidelis Care which he co-founded in 1996. Upon Centene’s acquisition of Fidelis for $3.75 billion in 2018, he led the successful integration of Fidelis into Centene before promotion to a senior leadership position at Centene reporting directly to Michael Neidorrf, Centene Chairman and CEO.
Under Frawley’s leadership, Fidelis grew rapidly in membership, programs, and services after securing initial financial sponsorship from the Roman Catholic Bishops of New York State. Fidelis expanded from a Brooklyn service area to serving 2 million members throughout New York State. The proceeds of the sale of Fidelis to Centene formed the Mother Cabrini Health Foundation with assets $3 Billion, extending the historic Fidelis mission to address the health and social service needs of vulnerable populations in New York State.
Prior to founding Fidelis, Frawley served as Associate Executive Director of Mary Immaculate Hospital, a 270-bed acute care facility, where he was responsible for ambulatory care services. He has served on the boards of health care, social service, and charitable organizations. He holds a Master’s degree in Health Administration from New York University, a JCL degree in Canon Law from Catholic University, a Master of Divinity degree from Immaculate Conception Seminary, and a Bachelor degree in Classics from Cathedral College.
Robert G. Funari
Chairman, NxStage Medical and Patient Care America
Former President and CEO, Syncor International; former Corporate Vice President, Baxter International
Mr. Funari is currently Chairman of NxStage Medical and Patient Care America, having sold Crescent Healthcare, a provider of infusion therapy services to patients with complex disease problems, to Walgreens in June 2012. He is also on the Memorial Care Foundation Board in Long Beach. Previously, he was the president and CEO of Syncor International, a nationwide provider of radio pharmacy services supporting nuclear medicine, which was acquired by Cardinal Health at the end of 2002. Prior to joining Syncor International, he was corporate vice president at Baxter International, leading their Pharmaseal and Paramax Systems Divisions, as well as their Medcom subsidiary. Mr. Funari has over 28 years of experience managing health care service, medical device, and instrumentation companies.
He formerly served on the boards of directors of Beckman Coulter, Bay Cities National Bank (chairman), Community First Financial Group, and First Consulting Group. He received his BS in mechanical engineering from Cornell University and his MBA from Harvard Business School.
Pedro José Greer, Jr., MD, FACP, FACG
Professor and Founding Dean, College of Medicine, Roseman University of Health Sciences; Trustee, RAND Corporation
Former Professor and Associate Dean of Community Engagement, Florida International University Herbert Wertheim College of Medicine
Pedro "Joe" Greer, Jr., M.D. is professor and founding dean of Roseman University College of Medicine. Previously, he served as Professor and Founding Chair of the Department of Humanities, Health and Society, and Associate Dean of Community Engagement at Florida International University Herbert Wertheim College of Medicine. He has served as a RAND Corporation trustee for almost two decades and chaired the Pardee RAND Graduate School Board of Governors 2011 to 2020, as well as an advisory board member for RAND Health.
Greer is recognized as an international leader on vulnerable populations, social accountability, health equity, reform in medical education, and innovation in community health delivery. In 1984, he founded "Camillus Health Concern," the only free-standing comprehensive health care center for the homeless in Miami-Dade County, and Saint John Bosco Clinic in 1991, a primary care clinic dedicated to serving undocumented families. He has received several prestigious awards, including the MacArthur "Genius" Fellowship, Doctor of the Year Award for Teaching, the Presidential Service Award, and the 2009 Presidential Medal of Freedom, among others.
Senior Partner Emeritus, McKinsey & Company
Former McKinsey and Company Healthcare Practice Leader
Ajay Gupta is Senior Partner Emeritus with McKinsey and Company. He brings almost 30 years of experience across health care segments. Ajay covers commercial and growth topics, corporate strategy, M&A, large scale performance improvement, organization design and aspiration setting. He led McKinsey’s Midwest Healthcare Practice and North America Medical Products. Ajay served medical technology, pharma/biotech, health systems, academic centers, post-acute providers, drug store chains, specialty pharmacy, PBMs, HCIT, distributors/other intermediaries, and disease management. Ajay has published articles on new therapy adoption, commercial excellence, pricing/contracting, digital marketing, industry consolidation and M&A and he is passionate about health care policy. His experience covers ambulatory, acute and post-acute care settings.
Ajay serves on the Boards of the Shirley Ryan Ability Lab, Healthium Medtech, BJC Healthcare, and OnPoint Surgical. He is also an active private investor. Prior to McKinsey, Ajay spent 5 years with Schlumberger Wireline in Europe and Asia. He holds an MBA from Stanford University, and a Bachelor of Technology from the Indian Institute of Technology, Delhi.
Karen Hein, MD
Former member, Green Mountain Care Board, Vermont; former President, William T. Grant Foundation
Dr. Hein was one of five members appointed by Vermont Governor Shumlin in 2011 to The Green Mountain Care Board (GMCB) to implement the state’s visionary, comprehensive health care reform law. The GMCB oversees and regulates Vermont’s hospital budgets, insurance rates, CON’s, workforce plan, and a unified health budget in its efforts to both moderate cost and improve health for all Vermonters.
Dr. Hein was president of the William T. Grant Foundation and is currently adjunct professor, Dept. of Family & Community Medicine at Dartmouth Medical School. She served on the U.S. Senate Finance Committee professional staff in the 1990's, and as executive officer of the Institute of Medicine 1994–98. Dr. Hein worked for a decade to promote global peace mostly in Asia and Africa. She serves on International Rescue Committee Overseers and RWJF Clinical Scholars National Advisory Committee. Her book, AIDS: Trading Fears for Facts, has sold over 100,000 copies. Dr. Hein graduated from the University of Wisconsin, attended Dartmouth Medical School, and received her medical degree from Columbia University, College of Physicians and Surgeons.
Howard A. Kahn
Former CEO, L.A. Care Health Plan; former Senior VP for Latin America and Global Health, CIGNA International; former VP, Aetna; founding President and CEO, California Wellness Foundation; founding CEO, Health Plan of San Mateo
Howard A. Kahn is former CEO of L.A. Care Health Plan, the nation's largest publicly operated health plan with more than 2 million enrolled members in Los Angeles County.
Kahn has more than 30 years of experience in national and international health care. At CIGNA International, he was Senior VP for Latin America and Global Health, and as a VP at Aetna, he was responsible for the company's global health business and nationwide governmental managed care operations. He was founding president and CEO of the $1billion California Wellness Foundation and founding CEO of the Health Plan of San Mateo.
Howard, in addition to occasional C-level consultations, serves as a board member for Charles Drew University School of Medicine, Physicians for a Healthy California, Good Hope Medical Foundation, and the Insure the Uninsured Project. He has served as chair for numerous Health Plan industry associations and recently led an LA-based homeless services agency through growth and transition. Kahn pursued undergraduate studies at Harvard, received his Bachelor's degree in Development Studies from UC Berkeley and his Master's degree in Public Affairs from the University of Minnesota's Humphrey Institute.
Joseph S. Konowiecki
Chairman, Alignment Health Inc.; Managing Partner, Moriah Partners, LLC
Former CEO of United Health’s Future Solutions unit; former General Counsel and EVP PacifiCare Health Systems
Mr. Konowiecki serves as managing partner of Moriah Partners, LLC, which oversees Moriah Growth Fund, dedicated to building emerging companies to become Market leaders. Mr. Konowiecki is also currently chairman and CEO of Apollo Enterprise Solutions, Inc., the leader in advanced self-managed solutions for large financial enterprises. Mr. Konowiecki also currently services as Chairman of Alignment Health Inc. Mr. Konowiecki was previously CEO of Future Solutions with UnitedHealth Group’s Ovations division, focusing on products and services for individuals over 50.
Mr. Konowiecki has also held the positions of general counsel and executive vice president corporate affairs at PacifiCare Health Systems, Inc., one of the nation's largest consumer health organizations. In addition, he is a founding partner of the law firm Konowiecki & Rank, where his areas of practice included health care, regulatory, mergers and acquisitions, corporate, partnership, securities, general business, and real estate. In the health care sector, Mr. Konowiecki has represented nonprofit and proprietary hospitals, preferred provider organizations, full-service and specialty HMOs, and all forms of medical groups. He has also led some of the largest health care public offerings and mergers in the country.
Managing Director, Global Head of Healthcare & Real Estate Groups, Barclays
Rick Landgarten is the Head of the Global Healthcare and Global Real Estate Groups. Prior to Barclays, Rick was Co-Head of Citigroup's Healthcare Group from 2000 to 2008. He also was a Director in the Healthcare Group at Donaldson, Lufkin & Jenrette. Rick has completed over 100 book-run financing and M&A transactions in the last 6 years with 25+ years of investment banking experience.
He has advised clients across a range a transaction types including M&A, IPOs, follow on equity, private placements, etc. Core client base includes companies across health care services including hospital, surgery center, physician groups, payor and payor services businesses, and health care information and data and analytics providers, clinical research organizations and behavioral health companies. A small sample of clients include, HCA, Press Ganey, Lifepoint, Centene, United Health, Tenet, United Surgical Partners, Multiplan, Quintiles, etc. Rick received his MBA from the Columbia Business School and a BS from Washington University in St. Louis.
Managing Partner, BrainFrees
Founder and CEO, VT&T; founder, Manchester International Incorporated
Mr. Metzger is currently Managing Partner of BrainFrees, a consultancy providing services to HealthCare providers, investors and HealthCare technology companies.
Mr. Metzger was founder & CEO of VT&T, a cloud based online collaboration solution, as well as CEO of a broadband transport & services company headquartered in Austin Texas. Mr. Metzger was the founder of Manchester International Incorporated. MII provided strategy, business development, and investment consulting to telecommunications carriers, computer companies, and network equipment providers.
He has enjoyed positions in marketing, operations, sales, and general management with IBM, Fujitsu, AT&T, and Harris Corporation.
In addition to Chairing AngelWorks, a philanthropic organization focused on cancer research, Mr. Metzger was Chairman of the Board of the Boys and Girls Clubs of Monterey, California; as well as a national trustee for the Boys and Girls Clubs of America, and trustee for the Hockaday School of Dallas. He has served on public and private company boards.
Edward J. Mullen
Former Senior Client Partner, Healthcare Practice, Korn/Ferry International; former President and CEO, Unihealth Managed Care Division
Mr. Mullen, recently retired, served the last 20 years as a Senior Client Partner for Korn/Ferry International, overseeing their health care practice for the western U.S. In this role he worked with hospitals, health care systems, insurance organizations and related health care for-profit and non-profit companies, assisting with filling their senior (C-Suite) leadership positions. He was very active in the firm's national Nonprofit and Financial Services Practices.
Prior to joining Korn/Ferry in 1998, he served as president and CEO of the managed care division of UniHealth—a large health system in Southern California. In this capacity, Mr. Mullen served on the senior leadership team of the $2 billion parent company and directed managed care strategy and contracting efforts for their eight acute care hospitals and related medical groups and companies. Earlier in his career, he held CEO roles at psychiatric hospitals with companies such as Hospital Corporation of America, and consulting roles with firms such as Ernst and Young. Ed has also been active on many national and community boards, including the Alliance for Children's Rights (past president) and Health Insights, a national hospital association (past chairman).
Mr. Mullen holds a Master's degree in public health administration (MPH) from Yale University and a Bachelor's degree in psychology from St. Louis University.
Mary D. Naylor, Ph.D., FAAN, RN
Marian S. Ware Professor of Gerontology and Director of New Courtland Center for Transitions and Health, University of Pennsylvania School of Nursing; Program Director for the Interdisciplinary Nursing Quality Research Initiative of The Robert Wood Johnson Foundation
Former Commissioner of the Medicare Payment Advisory Commission
Mary D. Naylor, PhD, FAAN, RN, is the Marian S. Ware professor in gerontology and director of the NewCourtland Center for Transitions and Health at the University of Pennsylvania School of Nursing. Since 1989, Dr. Naylor has led an interdisciplinary program of research designed to improve the quality of care, decrease unnecessary hospitalizations, and reduce health care costs for vulnerable community-based elders. Dr. Naylor is also the national program director for the Robert Wood Johnson Foundation program, the Interdisciplinary Nursing Quality Research Initiative, aimed at generating, disseminating, and translating research to understand how nurses contribute to quality patient care. She was elected to the National Academy of Sciences, Institute of Medicine in 2005. She also is a member of the National Quality Forum Board of Directors and the immediate past chair of the Board of the Long-Term Quality Alliance. She was appointed to the Medicare Payment Advisory Commission in 2010.
Bradley A. Perkins, MD, MBA
Co-Founder and Chief Executive Officer, Sapiens Data Science, Inc.; founding Chief Medical Officer, Human Longevity, Inc.
Former Executive Vice President, Vanguard Health Systems; former Chief Strategy and Innovation Officer, Centers for Disease Control and Prevention
Brad Perkins is a physician, scientist, and entrepreneur. He is currently Co-Founder and Chief Executive Officer of Sapiens Data Science, Inc., based in San Francisco, CA: "Sapiens turns science into action." Prior to co-founding Sapiens in 2018, Brad was the founding Chief Medical Officer (2014-2017) for Human Longevity, Inc. (HLI), where he designed, built, and operated the Health Nucleus, a leading precision medicine research platform with genomics pioneer J. Craig Venter.
Brad served as Executive Vice President (2009-2013) for Strategy and Innovation and Chief Transformation Officer at Vanguard Health Systems, a multi-state integrated health system in the run-up to its IPO with 46,000 employees and revenue of $6B+ and subsequent sale to another publicly-traded healthcare company. Brad started his career (1989) at the Centers for Disease Control and Prevention (CDC) where he led and was involved in many high profile scientific successes and investigations in the U.S. and globally; he led the 2001 U.S. anthrax bioterrorism investigations following 9/11. He served as the Chief Strategy and Innovation Officer (2003-2009) at CDC. Brad is Board-certified in Internal Medicine. He is an active private investor in human health and commercial spaceflight. He is a member of Esther Dyson's Wellville Advisory Board and Patron Member of the Commercial Spaceflight Federation. He lives and works in San Diego and San Francisco.
S. Louise Phanstiel
Chair, Board of Directors, Myriad Genetics, Inc.
Former President, Specialty Products and Senior Vice President and Chief Accounting Officer, Wellpoint, Inc.
S. Louise Phanstiel serves as the Chair of the Board of Directors of Myriad Genetics, Inc., a leading global precision medicine company with pioneering molecular diagnostics. Ms. Phanstiel held several executive positions at Anthem, Inc., formerly WellPoint, Inc. including President, Specialty Products; Senior Vice President, Chief of Staff to the Chairman and CEO and Chief Accounting Officer. Ms. Phanstiel previously was a partner at the international services firm PricewaterhouseCoopers, LLP, formerly Coopers & Lybrand, LLP, where she specialized in its insurance practice.
Ms. Phanstiel's life science experience also includes having previously served on the Board of Directors of Inveresk Research Group, Inc., then the world’s largest pre-clinical safety and pharmacology evaluation services company and Verastem Oncology, a development-stage biopharmaceutical company committed to the development of new medicines to treat cancer.
Ms. Phanstiel has served on the Board of Directors of Cedars-Sinai Health System, one of the largest nonprofit academic medical centers in the country. She currently serves on the Board of Trustees of Syracuse University and Southampton Hospital Association.
Arnold L. Porath
President and CEO, Charter Group; Principal, Spruce Healthcare Group
Former Vice Chair of the UCLA Medical Center Board of Advisors
Arnold Porath is president and CEO of Charter Group, a national real estate investment company that owns and develops outpatient medical facilities and medical office buildings, and develops other real estate assets including affordable housing.
For over 25 years, Mr. Porath has served in various leadership capacities at UCLA Medical Center, including serving as Vice-Chair of its Board of Advisors during the construction of the UCLA Medical Plaza and Ronald Reagan UCLA Medical Center. He has been an active member of the UCLA Medical Center Ethics Committee for over 20 years, during which he has participated in hundreds of consults with patients, family members and staff. This experience led him to co-found the UCLA Health Ethics Center in 2002, and in 2011, created and endowed Clinical Ethics Fellowships within the Center. He serves on the RRI Collaborative, working to reduce hospital readmissions focusing on performance improvement and patient safety.
Mr. Porath’s additional current and past board affiliations include the Aspen Community Foundation, the Music Associates of Aspen, the Los Angeles Music Center Leadership Council, and National Homes Trust "Campus of Opportunities," providing job training and computer skills to low income communities.
Mr. Porath and his wife, Anne, divide their time between Santa Monica, California and Aspen, Colorado.
Thomas M. Priselac
President and CEO, Cedars-Sinai Health System
Thomas M. Priselac is President and Chief Executive Officer of the Cedars-Sinai Health System—a position he has held since January 1994.
Mr. Priselac has been associated with Cedars-Sinai since 1979. Prior to being named President and CEO, he was Executive Vice President from 1988 to 1993. Before joining Cedars-Sinai, he was on the executive staff of Montefiore Hospital in Pittsburgh.
Mr. Priselac has served the health care field in various roles during his career at Cedars-Sinai. He is a past Chair of the American Hospital Association Board of Trustees and also a past Chair of the Association of American Medical Colleges. Prior to those roles, he chaired the Hospital Association of Southern California, the California Healthcare Association, and the Association of American Medical Colleges Council of Teaching Hospitals. The holder of the Warschaw/Law Endowed Chair in Healthcare Leadership at Cedars-Sinai Medical Center, Mr. Priselac also serves as an adjunct professor at the UCLA School of Public Health.
A native of Pennsylvania, Mr. Priselac obtained a Bachelor's degree in Biology from Washington and Jefferson College in Pennsylvania, and a Master's in Public Health, Health Services Administration and Planning, from the University of Pittsburgh.
Senior Advisor, Manatt Health Solutions
Former CEO, Visiting Nurse Service of New York; former Board Chair, AARP
Carol Raphael is a Senior Adviser at Manatt Health Solutions. She served as Chief Executive Officer of the Visiting Nurse Service of New York (VNSNY), the largest non-profit home health agency in the United States for 22 years. She also served as Board Chair of AARP. Prior to joining VNSNY, Ms. Raphael held executive positions at Mt. Sinai Medical Center and the Human Resources Administration in New York City. She is chair of the Board of the Long Term Quality Alliance and vice-chair of the Boards of the Primary Care Development Corporation and the Commonwealth Care Alliance. She is a member of the Boards of the Kaiser-Permanente School of Medicine, The Scan Foundation, the Medicare Rights Center, the New York eHealth Collaborative, Henry Schein, Inc. and the T.H. Chan School of Public Health Policy & Management Executive Council. She has been appointed to many commissions including the Medicare Payment Advisory Commission (MedPAC),the Federal Bipartisan Commission on Long Term Care and the Age-Friendly Commission. She co-edited the book Home-Based Care for a New Century and was a Visiting Fellow at the Kings Fund in the United Kingdom.
Scott C. Ratzan, MD, MPA
Editor-in-Chief, Journal of Health Communication: International Perspective, and Distinguished Lecturer, CUNY Graduate School of Public Health and Health Policy
Former President, AB InBev Foundation
Dr. Ratzan is engaged in advancing multisector engagement for sustainable health. He is Distinguished Lecturer at CUNY Graduate School of Public Health and Health Policy where is developing Health Communication for Social Change efforts, as well as leading the development of Business Partners for Sustainable Development with the U.S. Council for International Business foundation. He recently was Senior Fellow at Mossavar-Rahmani Center for Business & Government, at Harvard Kennedy School developing Guiding Principles for Multisector Engagement and a series of articles on vaccine acceptance. Dr. Ratzan is also Editor-in-Chief of the Journal of Health Communication: International Perspectives.
He was founding President of the AB InBev Foundation, and now serves and a Director. He had eleven years of experience in Vice President roles at Johnson & Johnson at headquarters and in Brussels. Before his private sector engagement, he worked at the U.S. Agency for International Development (USAID) in Washington DC, and in academia as a professor and Founding Director of the Emerson-Tufts Masters Program in Health Communication. He currently serves on the Board of Global Health for the National Academies of Science, Engineering and Medicine and has previously been on the Board of Scientific Counselors for the Centers for Disease Control and Prevention, Office of Infectious Disease.
Dr. Ratzan received his MD from the University of Southern California, an MPA from Harvard Kennedy School, and an MA from Emerson College. His academic appointments include Adjunct Professor at Columbia University Mailman School of Public Health, Tufts University School of Medicine, and George Washington University.
Lonny Reisman, MD, FACC
Founder and CEO, HealthReveal
Former Chief Medical Officer, Aetna; former Founder and CEO, ActiveHealth Management
Lonny is Founder and CEO of HealthReveal. HealthReveal is a clinical AI company dedicated to mitigating avoidable consequences for patients who suffer from chronic disease. Previously, Lonny served as Aetna's Chief Medical Officer for six years. During his tenure there, he was responsible for the company's clinical strategy and helped build a better system supported by evidence-based accountability. Prior to this, Lonny was CEO of ActiveHealth Management where he co-founded ActiveHealth Management, now an Aetna subsidiary.
Lonny is a member of the Harvard Medical School Health Care Policy Committee; the New York eHealth Collaborative Board of Directors; the East Coast CMO Executive Summit Committee; the New York City Health and Hospitals Corporation OneCity Health Executive Committee; and the American College of Cardiology Science and Quality Committee.
Lonny was an attending physician at New York Hospital and St. Luke's-Roosevelt Hospital Center, and he was a cardiology fellow at the University of Chicago. He received his undergraduate degree from the SUNY Stony Brook and his medical degree from Tel Aviv University.
Vice Chairman, Investment Banking and Chairman, Global Healthcare Group, Lazard
Mr. Sands, Vice Chairman of Investment Banking and Chairman of the Global Healthcare Group at Lazard, has built a 25-year career providing strategic and financial advice to leading health care and life sciences companies globally. Prior to joining Lazard, Mr. Sands was a Partner in the health care practice of McKinsey & Company. During his career, he co-founded two life sciences companies: Enzytech and Opta Food Ingredients. Mr. Sands currently is a director of Cognition Therapeutics.
Mr. Sands is a member of the Rockefeller University Counsel; Washington University in St. Louis School of Engineering & Applied Science National Counsel; trustee of the New York Hall of Science; and member of the Columbia University Science Advisory Committee. He has received the New York Biotechnology Association's The Cures Start Here Business Leader of the Year Award (2008) and Washington University Alumni Achievement Award (2014).
Mr. Sands earned a BA in Biology from Oberlin College, a BS and MS in Chemical Engineering from Washington University in St. Louis, and a MBA in Finance from New York University.
Nirav R. Shah, MD, MPH
Chief Medical Officer of Sharecare; Senior Scholar, Stanford School of Medicine
Former Chief Operating Officer, Kaiser Permanente Southern California; former Commissioner, New York State Department of Health
Nirav R. Shah, MD, MPH, is the Chief Medical Officer of Sharecare, a leading digital health company that helps people with a comprehensive and data-driven virtual health platform designed to optimize individual and population-wide well-being by driving positive behavior change. In addition, he is Senior Scholar at Stanford University’s School of Medicine. He is a leader in digital health and innovation, care transformation, patient safety and quality, and the strategies required to transition to high-value, patient-centered care.
Dr. Shah's expertise spans health and health care as a member of the HHS Secretary’s Advisory Committee, as Senior Fellow of the Institute for Healthcare Improvement (IHI), and as an independent director of public and private companies and foundations. Previously, he served as Chief Operating Officer of Kaiser Permanente in Southern California, and as Commissioner of the New York State Department of Health.
Board-certified in Internal Medicine and caring for patients at Stanford, Dr. Shah is a graduate of Harvard College and Yale School of Medicine, and he is an elected member of the National Academy of Medicine.
Former Chief Innovation Officer, GE and Chief Executive Officer, GE Ventures; former General Partner, Mohr Davidow Ventures; former President Affymetrix
As former Chief Innovation Officer, GE and CEO, GE Ventures, Sue Siegel led the development and acceleration of innovation across GE for seven years. She oversaw investment in promising startups, creating and scaling new companies and commercializing GE's intellectual property. She also led strategy planning and oversaw the global marketing function.
Before joining GE, Sue was a General Partner at Mohr Davidow Ventures, where she spearheaded investments in personalized medicine, digital health, and life sciences. Prior to becoming a venture capitalist, she led Affymetrix as President and a board member, and held executive leadership roles at Bio-Rad, DuPont, and Amersham after early work in molecular biology and biochemistry.
Sue is currently a board member at Align Technologies (ALGN), Illumina (ILMN), MIT’s The Engine, and the Kaiser Family Foundation. Additionally, she serves on the advisory boards for Harvard Partners Healthcare Innovation, University of California Innovation Council, RAND Health Care and the U.K. National Health Services Digital Academy. She co-chairs Stanford Medicine Board of Fellows. Sue has also served on numerous nonprofit boards.
C. Jason Wang, MD, Ph.D.
Director, Center for Policy, Outcomes, and Prevention, and Professor of Pediatrics and Medicine, Stanford University; Dean, The New School for Leadership in Health Care, Koo Foundation sun Yat-Sen Center, Taipei, Taiwan
C. Jason Wang is Director of the Center for Policy, Outcomes, and Prevention, and Associate Professor of Pediatrics and Medicine at Stanford University. He also co-chairs the mobile health and other new technologies group at the Center for Population Health Sciences. He received his BS from MIT, MD from Harvard Medical School, and PhD from RAND. After residency at UCSF, he worked in Greater China with McKinsey and Company. In 2000, he was recruited to serve as the project manager for Taiwan's Healthcare Reform Taskforce. In 2012, he co-founded MedicusTek (now Cognito Health), focusing on predictive patient monitoring and patient safety. He was selected as the student speaker for Harvard Medical School's commencement ceremony in 1996, a recipient of the 2011 NIH Director's New Innovator Award, and a speaker for Johns Hopkins Bloomberg School of Public Health 100th Year's Child Health Policy Symposium. His recent work on COVID-19 has been published in JAMA, Science, BMJ and featured in 273 media outlets world-wide, including Time, New York Times, WSJ, CNN, BBC, and Al Jazeera.
Jeffrey A. Weiss
Founder and Managing Director, CCI, Inc.; co-founder, SO/CAL/TEN
Jeff Weiss founded CCI, Inc. in 1986. CCI runs exclusive, ongoing forums where CEOs and senior executives from Global 1000 firms and large health care systems can explore strategies and growth. CCI is partnered with major global consulting firms. Previously, Jeff co-founded SO/CAL/TEN, 210 technology CEOs, and was recognized by Inc. and Fortune as one of the first high tech networking organizations. He was Assistant Clinical Professor of Psychiatry at UCLA and served as Director of Behavioral Medicine at the UCLA-San Bernardino County Medical Center Family Practice Residency. He was on the Board of the California Academy of Family Practice Foundation and was a Trustee of CSPP. He is currently on the Board of AltaMed Foundation, SCS Noonan Scholars, and Equality Health. A licensed psychologist, he holds a PhD in Clinical Psychology from the California School of Professional Psychology and a postdoctoral fellowship at the University of Tennessee Medical School.
Phyllis M. Wise
CEO, Colorado Longitudinal Study
Former Chancellor, University of Illinois at Urbana-Champaign; former Provost and Executive Vice President, University of Washington
Phyllis M. Wise is the CEO of the Colorado Longitudinal Study. Prior to this appointment she has served as the leader of highly respected public research intensive universities including Chancellor of the University of Illinois at Urbana-Champaign and Provost and Executive Vice President and Interim President at the University of Washington. She is a member of the National Academy of Medicine and the American Academy of Arts and Sciences, and a fellow of the American Association for the Advancement of Science and the American Physiological Society. Phyllis holds positions on the governing boards of the Robert Wood Johnson Foundation, Nike, and the First Busey Corporation. She holds a bachelor’s degree from Swarthmore College in Biology and a doctorate degree in zoology from the University of Michigan. Phyllis was awarded an honorary doctorate from Swarthmore College and from the University of Birmingham (England).
Managing Partner, Arrowwood Partners, LLC
Susan Hullin is managing partner of Arrowwood Partners, LLC, a firm that provides strategic corporate communications counsel. Her experience is wide-ranging, and includes key positions with global public relations firms.
Ms. Hullin has directed communications programs for a number of global corporations, and has handled strategic communications on behalf of portfolio companies for one of the world's largest venture capital firms specializing in health care. She has provided counsel on a number of mergers and acquisitions, on many issue management programs and crisis situations, and has served as a member of legal teams in support of litigation.
Ms. Hullin serves on the National Advisory Council of the New Jersey Conservation Foundation and on the Advisory Council of Greener New Jersey Productions. She most recently served as a Trustee of the Economic Club of New York and its membership co-chair. She is a member of the National Press Club and was named to the YWCA Academy of Women Achievers.
Ms. Hullin received a Bachelor’s degree in Political Science from the University of Washington.